StockData
Aptevo Therapeutics Inc. logo

Aptevo Therapeutics Inc. (APVO) stock

APVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.46−0.09 (-15.97%)

Close on Nov 17, 2026Market cap $830.71KP/E –Yield –

Aptevo Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Aptevo Therapeutics's price to sales ratio was 438.7× on Apr 30, 2020.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Apr 30, 2020438.7×–

More Aptevo Therapeutics figures

See a number that looks wrong?